Pregnant and breast-feeding patients, those with severe liver/renal insufficiency, those on long term follow up prior to the commencement of the study or patients and /or their caregivers unwilling to provide written informed consent were excluded. Relevant medical data were obtained by personal interview of communication with patients and/or their caregivers, examination of electronic medical records and assessment using validated questionnaires. Secondary stroke preventionPatients were evaluated on their first visit after discharge (7±3 days) for baseline knowledge and awareness regarding the disease using locally prepared validated questionnaire and medication adherence using Morisky Medication Adherence 8item scale. [10][11][12] and reassessed during follow up visit. The patients were provided with stroke education